Global Genome Engineering Editing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Genome Engineering Editing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Genome Engineering Editing report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Genome Engineering Editing market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Agriculture and Medical are the major drivers for the industry.
Genome engineering editing refers to the use of tools such as CRISPR-Cas9 to precisely edit and modify the genome of an organism to achieve specific gene improvement and functional regulation. With the development of genome engineering editing technology, the future trend is to continuously improve and enhance the accuracy and efficiency of editing technology. This includes improving the specificity and accuracy of the CRISPR-Cas9 system, reducing the incidence of non-specific splicing events, and increasing editing efficiency and success.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Genome Engineering Editing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
Segment by Type
Homologous Recombination
Meganuclease
Agriculture
Medical
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Genome Engineering Editing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Genome Engineering Editing introduction, etc. Genome Engineering Editing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Genome Engineering Editing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
Genome engineering editing refers to the use of tools such as CRISPR-Cas9 to precisely edit and modify the genome of an organism to achieve specific gene improvement and functional regulation. With the development of genome engineering editing technology, the future trend is to continuously improve and enhance the accuracy and efficiency of editing technology. This includes improving the specificity and accuracy of the CRISPR-Cas9 system, reducing the incidence of non-specific splicing events, and increasing editing efficiency and success.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Genome Engineering Editing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
Segment by Type
Homologous Recombination
Meganuclease
Segment by Application
Agriculture
Medical
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Genome Engineering Editing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Genome Engineering Editing introduction, etc. Genome Engineering Editing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Genome Engineering Editing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.